Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 28;14(1):72.
doi: 10.1007/s13668-025-00664-x.

Lactiplantibacillus Plantarum as a Complementary Approach for Diabetes Treatment and Management

Affiliations
Review

Lactiplantibacillus Plantarum as a Complementary Approach for Diabetes Treatment and Management

Akash Kumar et al. Curr Nutr Rep. .

Abstract

Purpose of review: This review explores the impact of Lactiplantibacillus plantarum on diabetes management and discusses the potential mechanism.

Recent findings: Recent studies have highlighted that gut dysbiosis has emerged as a key factor in the development of diabetes. In this context, probiotics, specifically Lactiplantibacillus plantarum, offer potential benefits in modulating gut microbiota and improving metabolic health. Several studies have demonstrated the positive impact of L. plantarum on glycemic control, insulin sensitivity, and inflammatory markers in diabetic animal models. The potential mechanisms of action of L. plantarum in diabetes management include inhibiting enzymes involved in glucose metabolism, modulating inflammatory responses, improving insulin sensitivity, restoring gut microbiota, and producing short-chain fatty acids.

Summary: The article concludes that L. plantarum is a promising candidate for managing glucose hemostasis, thus offering a potential alternative or adjunct to conventional approaches. However, further clinical studies are necessary to understand the exact mechanism and long-term effects of L. plantarum in humans.

Keywords: Gastrointestinal microbiome; Global health; Glycemic control; Insulin resistance; Probiotics.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing Interests: The authors declare no competing interests.

Similar articles

References

    1. Sapra A, Bhandari P, Diabetes. StatPearls [Internet]. 2023 [cited 2024 Aug 5]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK551501/
    1. Husein R, DepkesRI, Soelistijo SA, Novida H, Rudijanto A. BPJS, Classification of Diabetes Mellitus. Department for Management of NCD, Disability, Violence and Injury Prevention [Internet]. 2018 [cited 2024 Aug 5];138:271–81. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279119/
    1. Goyal R, Singhal M, Jialal I, Type D. 2023 [cited 2024 Aug 5]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK513253/
    1. Association American Diabetes. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care [Internet]. 2014 [cited 2024 Aug 5];37:S81–90. Available from: https://doi.org/10.2337/dc14-S081
    1. Pathak V, Pathak NM, O’Neill CL, Guduric-Fuchs J, Medina RJ. Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives. Clin Med Insights Endocrinol Diabetes [Internet]. 2019 [cited 2024 Aug 5];12. Available from: http://pmc/articles/PMC6501476/

LinkOut - more resources